PIA
OXFD

Piedmont Investment Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Piedmont Investment Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-441
Closed -$6K – 2675
2018
Q2 		$6K Buy
+441
New +$5.96K ﹤0.01% 2071

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Piedmont Investment Advisors's OXFD Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2018, closing a stake of 441 shares — an estimated $6K sold.

Piedmont Investment Advisors first reported a position in OXFD in Q2 2018 and held it in 1 quarter. The position peaked at $6K in Q2 2018. 83 funds tracked by Wall St. Rank hold OXFD as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 441 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2018, an estimated $6K.
  • Piedmont Investment Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $6K in Q2 2018.
  • 83 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.